Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1263 of 5804
-
Soothing sounds and scents may calm cancer patients during scary scans
Symptom relief CompletedMRI-related anxiety is prevalent among cancer patients and frequently undermines imaging quality by inducing motion artifacts or causing premature examination termination. Safe, non-pharmacological supportive interventions have the potential to alleviate procedural anxiety, yet t…
Phase: NA • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New drug BL-M17D1 targets Hard-to-Treat HER2 cancers in early trial
Disease control OngoingThe objective of this study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of BL-M17D1 in patients with HER2-Expressing or HER2-Mutant Advanced or Metastatic Solid Tumors.
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New online therapy aims to ease cancer Survivors' mental health struggles
Symptom relief Recruiting nowNegative psychological effects of cancer are common, but cancer survivors are rarely offered structured psychological treatment. Internet-delivered treatments have shown some promise, but specific treatment components have not been empirically evaluated which means that it is not…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New pill aims to tackle heart failure and obesity together
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, parallel design phase II clinical trial, including a screening period of up to 2 weeks, a 36-weeks' treatment period, and a 1-week safety follow-up visit period.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Breathe away your shyness: online breathwork therapy targets social anxiety
Symptom relief Recruiting nowThis study aims to investigate the potential of supplementing psychotherapy with breathing techniques as a new online therapeutic approach to reduce social anxiety (SA). Clinically significant SA affects a substantial portion of the population (about 13%) and is associated with s…
Phase: NA • Sponsor: Maastricht University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Ancient herb takes on PCOS: new hope for millions?
Disease control CompletedPolycystic Ovarian Syndrome (PCOS) is a multifaceted endocrine metabolic condition impacting about 5-10% of women throughout their reproductive lifespan. It is influenced by neuroendocrine dysfunction, insulin resistance, chronic low-grade inflammation, and ovarian oxidative stre…
Phase: PHASE1 • Sponsor: Jinnah Sindh Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a vitamin b derivative boost chemo for advanced colon cancer?
Disease control Recruiting nowThis is a clinical research study taking place in Germany. Patients with colorectal cancer at a stage of the disease where metastases occur may take part in the study. A maximum of 90 people will participate in the study. There is already a standard therapy for treatment of colo…
Phase: PHASE1, PHASE2 • Sponsor: Isofol Medical AB • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a smartphone app help children beat insomnia?
Symptom relief Recruiting nowThe proposed pilot will examine feasibility, acceptability, and preliminary efficacy of a digital CBT-I tailored for school-aged children.
Phase: NA • Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New monthly shot could tame stubborn high blood pressure
Disease control CompletedThe purpose of this study is to evaluate the blood pressure (BP)-lowering efficacy of tonlamarsen in adult participants who, despite taking 2 or more antihypertensive medications, have not achieved their target blood pressure (BP).
Phase: PHASE2 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can writing in groups help teens heal from complex trauma?
Symptom relief Recruiting nowThis study aims to examine the effectiveness of group-delivered Guided Written Exposure Therapy for Complex Post-Traumatic Stress Disorder (GWE-C) among Chinese adolescents through a randomized controlled trial. A total of 120 participants will be recruited, with 60 randomized to…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Baby formula breakthrough? new study tests synbiotics to stop eczema before it starts
Prevention Recruiting nowThe main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well.
Phase: NA • Sponsor: Société des Produits Nestlé (SPN) • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
New combo pill aims to tackle diabetes and hypertension at once
Disease control Recruiting now\[Primary Objective\] To demonstrate the superiority of the change in mean sitting systolic blood pressure (MSSBP) and hemoglobin A1c (HbA1c)on week 12 of the combination therapy of THP-00101 (dapagliflozin 10 mg) and THP-00102 (telmisartan 80 mg) compared to THP-00101 or THP-001…
Phase: PHASE3 • Sponsor: THPharm Corp. • Aim: Disease control
Last updated Jun 26, 2026 16:18 UTC
-
New drug hopes to stop liver scarring in its tracks
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a Stop-Smoking drug help Parkinson's patients stop falling?
Disease control Recruiting nowThis trial aims to test whether one year of Varenicline, when compared to placebo, can reduce fall risk and show improvement in the ability to multitask while walking. Participants that are eligible after screening for the study will be randomized to receive Varenicline or place…
Phase: PHASE2 • Sponsor: Vikas Kotagal • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to ease migrant mental health crisis with simple tools
Symptom relief Recruiting nowRationale: Migrant populations face numerous mental health risk factors, including unmet expectations, inadequate support, acculturation challenges, and legal hurdles. These stressors hinder their lives during and after migration. The World Health Organization has developed scala…
Phase: NA • Sponsor: Universita di Verona • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Common painkiller could boost immunotherapy in advanced lung cancer
Disease control Recruiting nowThis phase II trial tests how well diclofenac works in treating patients non-small cell lung cancer (NSCLC) that may have spread from where it first started (primary site) to other places in the body (metastatic) on single agent immunotherapy. Diclofenac, a type of non-steroidal …
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Gene test could prevent medication mishaps in hospitals
Knowledge-focused Recruiting nowIt is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effects or even coming to harm. Some of the differences in response to medications can be explained by our genes. Genes are sh…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug shows promise for controlling dangerous fat levels in blood
Disease control Recruiting nowThis is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (SHTG). Each participant must have completed all required visits per protocol in the parent study AROAPOC3-2003 (USA and Canada participants only; NCT# 05413135),…
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Knee surgery gets a boost: BioBrace scaffold tested in 500 patients
Disease control Recruiting nowThis research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.
Sponsor: CONMED Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Liver cancer trial tests combo therapy against single drug
Disease control Recruiting nowThe goal of this interventional study is to compare treatment response between transarterial chemoembolization (TACE) combined with lenvatinib and lenvatinib monotherapy in patients with unresectable hepatocellular carcinoma. The study aims to determine whether the addition of TA…
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC